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QUANTITATIVE MRI ASSESSMENT OF THE
PROGRESSION OF KNEE STRUCTURAL CHANGES IN
AN OSTEOARTHRITIS EXPERIMENTAL DOG MODEL:
CORRELATION WITH MACROSCOPIC FINDINGS
C. Boileau1, J. Martel-Pelletier1, F. Abram2, J-P. Raynauld1,
É. Troncy3, M-A. D’Anjou3, M. Moreau3, J-P. Pelletier1
1Osteoarthritis Research Unit, University of Montreal Hospital
Centre, Notre-Dame Hospital, Montreal, PQ, Canada;
2ArthroVision Inc., Montreal, PQ, Canada; 3Companion Animal
Research Group, Veterinary Teaching Hospital Centre,
University of Montreal, St-Hyacinthe, PQ, Canada
Purpose: Animal models have been used extensively to study
the pathophysiology of osteoarthritis (OA). Among them the ante-
rior cruciate ligament (ACL) dog model demonstrates the ability
to reproduce morphological and molecular changes of human
OA, and have been very useful for testing the effects of disease-
modifying osteoarthritis drugs (DMOAD). Magnetic resonance
imaging (MRI) technology provides precise and reliable quan-
titative information on joint tissue structure and changes over
time. Here, we investigated the reliability of quantitative MRI in
assessing OA joint structural changes in the ACL experimental
dog model over a period of 26 weeks.
Methods: OA was surgically induced by transection of the ACL
of the right knee (n=5). High resolution 3D MRI using a 1.5
T magnet was performed on the right knee at baseline, 4, 8
and 26 weeks post-surgery. Cartilage volume/thickness, cartilage
defects, osteophyte formation and subchondral bone lesions
(hypersignal) were assessed on MR images in the whole knee
as well as on the different anatomical subregions of the knee. The
dogs were sacriﬁced at week 26 and macroscopic evaluation of
the knee cartilage lesions and osteophyte size were performed.
Statistical analysis comparing values obtained at 4, 8 and 26
weeks to baseline was done by ANOVA followed by Tukey’s
multiple comparison test.
Results: Quantitative MRI analysis showed a progressive and
signiﬁcant increase in the loss of knee OA cartilage volume over
time (from -14.9±1.9%, P<0.001 at 4 weeks to -29.0±3.6%,
P<0.001 at 26 weeks), of incidence and size of cartilage defect
(from 1.31±0.28, P<0.001 to 3.23±0.12, P<0.001) and of sub-
chondral bone hypersignal (from 0.6±1.0 to 1.7±0.3, P<0.001).
The osteophyte size also progressed over time (from 4.8±0.8
mm, P<0.01 to 12.1±1.4 mm, P<0.001). Subregional analy-
sis revealed that the greatest cartilage volume loss was found
predominantly on the tibial plateaus and in the medial compart-
ment (medial femoral condyle and tibial plateau). There were
highly signiﬁcant correlations between cartilage loss or defect
and subchondral bone hypersignal (r=-0.81; r=0.75, both at a
P<0.0001). These ﬁndings from MRI correlated very well with
the macroscopic evaluation of cartilage lesions and osteophytes
26 weeks post-surgery.
Conclusions: This study demonstrated that MRI provides a
non-invasive and reliable quantitative assessment of the joint
structural changes during the development of OA in the ACL dog
model. The combination of this OA model with MRI evaluation
provides a powerful tool for the evaluation of the effectiveness of
new DMOADs.
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THE ROLE OF SOX9 IN JOINT FORMATION
S.P. Henry, L. Zhang, B. De Crombrugghe
University of Texas MD Anderson Cancer Center, Houston, TX
Purpose: The major goal of this study is to examine the function
of the transcription factor Sox9 in joint development and joint
homeostasis.
Methods: To study the role of Sox9 in joint formation, we have
obtained a transgenic driver mouse that expresses cre recombi-
nase in the developing joint called gdf5-cre and have bred this
mouse to a mouse containing a conditional Sox9 allele ﬂanked
by loxP sites (Sox9 ﬂox/ﬂox) in order to generate Sox9ﬂox/ﬂox:
gdf5-cre mice, in which the Sox9 gene should be inactivated in
the presumptive, developing joint.
Results: To our surprise, all mutant mice, Sox9ﬂox/ﬂox: gdf5-cre,
die at birth due to a diaphragmatic hernia and display shortened
forelimbs and hindlimbs. Some mutant mice die in utero be-
tween 15.5 and 16.5 days post coitum (dpc) due to massive
internal hemorrhaging caused by a complete lack of a sternum
(sternebrae are not formed) and a dramatically smaller rib cage.
However, a consistent phenotype observed amongst all mutant
animals is the bending of the ulna and humerus in the arm. In
many cases, the radius and humerus are fused at the elbow
joint,similar to the phenotype previously reported in the Noggin
null mice. In Sox9 mutants of strong penetrance, a complete lack
of interdigital joints is evident at 16.5 days post coitum. We are
currently performing RNA in situ hybridization experiments in the
mutant mice joints to analyze the expression of genes implicated
in joint formation; namely, gdf5, noggin, wnt9a, and sfrp-2. In
many mutants, gdf5 mRNA is not detected at the joint interzone
but rather is mislocalized to the cells surrounding the cartilage
anlagen in the digits at 13.5 dpc mutants. Further characteriza-
tion of Sox9ﬂox/ﬂox: gdf5-cre mutant mice should help delineate
the role of Sox 9 in joint formation.
Conclusions: The transcription Sox9 is essential for normal joint
formation. By inactivating the mouse Sox9 gene with a transgenic
gdf5-cre driver mouse, bony joint fusions are evident between
the radius and the humerus at 16.5 dpc. Furthermore, a com-
plete lack of interphalangeal joints is apparent in Sox9 mutants
of strong penetrance. The missing interphalangeal joints may
be caused by the mislocalization of the gdf5 mRNA from its
normal expression at the joint interzone to the outlying cells sur-
rounding the cartilage anlagen at 13.5 dpc of mouse embryonic
development.
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ORAL CALCITONIN PROTECTS AGAINST CARTILAGE
EROSION IN AN EXPERIMENTAL MODEL OF
OSTEOARTHRITIS
R.H. Nielsen, B-C. Sondergaard, C. Christiansen, M.A. Karsdal
Nordic Bioscience, Herlev, Denmark
Purpose: Osteoarthritis (OA) is a disease that affects the entire
articular joint. The optimal treatment would target both bone and
cartilage. Calcitonin has been shown to affect both osteoclasts
and chondrocytes. We investigated whether a novel oral for-
mulation of salmon calcitonin could attenuate cartilage damage
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